Quipt Home Medical Q3 Earnings Preview: EPS and Revenue Estimates
PorAinvest
viernes, 8 de agosto de 2025, 5:38 pm ET1 min de lectura
QIPT--
The company's stock has experienced significant fluctuations over the past year. In May, Quipt Home Medical reported an EPS of $0.07, missing analyst estimates by $0.09 and posting a negative net margin of 3.66% and a negative return on equity of 8.38% [1]. Institutional investors, including Jane Street Group, have shown ongoing interest in the company, with Jane Street recently acquiring a new stake [1].
Analysts' ratings for Quipt Home Medical have been mixed. Canaccord Genuity Group reissued a "hold" rating and set a $1.70 price target, while Benchmark reaffirmed a "buy" rating with a $4.00 price objective [1]. Wall Street Zen, however, downgraded Quipt Home Medical from a "hold" rating to a "sell" rating [1].
Market performance has been volatile for Quipt Home Medical. The stock price reached a 52-week low of $1.35 and a high of $3.37, with a current ratio of 1.22, a quick ratio of 0.85, and a debt-to-equity ratio of 0.76 [1]. The company's stock has been trading at $2.14 as of August 7th, down 31.25% over the last 52 weeks [3].
Looking ahead, investors will be closely monitoring Quipt Home Medical's Q3 earnings report. The company's ability to provide positive guidance and beat analyst estimates will be crucial in determining the stock's performance post-announcement. Analysts anticipate the company to report an EPS of $0.01, with bulls hoping for a beat and positive guidance [3].
References:
[1] https://www.marketbeat.com/instant-alerts/quipt-home-medical-qipt-to-release-quarterly-earnings-on-monday-2025-08-04/
[2] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3U025D:0-quipt-home-medical-corp-expected-to-post-breakeven-results-a-share-earnings-preview/
[3] https://www.benzinga.com/insights/earnings/25/08/47010037/insights-into-quipt-home-medicals-upcoming-earnings
Quipt Home Medical is set to announce Q3 earnings results on August 11th. The consensus EPS estimate is -$0.07, a 75% YoY decline, while the revenue estimate is $57.51M, a 10.1% YoY decrease. Over the last year, QIPT has seen significant fluctuations in its earnings and revenue.
Quipt Home Medical (NASDAQ:QIPT) is set to release its Q3 2025 earnings results on Monday, August 11th. The consensus EPS estimate stands at -$0.07, marking a 75% year-over-year (YoY) decline, while the revenue estimate is projected to be $57.51 million, a 10.1% YoY decrease [1].The company's stock has experienced significant fluctuations over the past year. In May, Quipt Home Medical reported an EPS of $0.07, missing analyst estimates by $0.09 and posting a negative net margin of 3.66% and a negative return on equity of 8.38% [1]. Institutional investors, including Jane Street Group, have shown ongoing interest in the company, with Jane Street recently acquiring a new stake [1].
Analysts' ratings for Quipt Home Medical have been mixed. Canaccord Genuity Group reissued a "hold" rating and set a $1.70 price target, while Benchmark reaffirmed a "buy" rating with a $4.00 price objective [1]. Wall Street Zen, however, downgraded Quipt Home Medical from a "hold" rating to a "sell" rating [1].
Market performance has been volatile for Quipt Home Medical. The stock price reached a 52-week low of $1.35 and a high of $3.37, with a current ratio of 1.22, a quick ratio of 0.85, and a debt-to-equity ratio of 0.76 [1]. The company's stock has been trading at $2.14 as of August 7th, down 31.25% over the last 52 weeks [3].
Looking ahead, investors will be closely monitoring Quipt Home Medical's Q3 earnings report. The company's ability to provide positive guidance and beat analyst estimates will be crucial in determining the stock's performance post-announcement. Analysts anticipate the company to report an EPS of $0.01, with bulls hoping for a beat and positive guidance [3].
References:
[1] https://www.marketbeat.com/instant-alerts/quipt-home-medical-qipt-to-release-quarterly-earnings-on-monday-2025-08-04/
[2] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3U025D:0-quipt-home-medical-corp-expected-to-post-breakeven-results-a-share-earnings-preview/
[3] https://www.benzinga.com/insights/earnings/25/08/47010037/insights-into-quipt-home-medicals-upcoming-earnings

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios